- Home
- NHP vs SLS Comparison
NHP vs SLS Comparison
Compare NHP & SLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
HOLD
Current Price
$12.54
Company Overview
Basic Information| Metric | NHP | SLS |
|---|---|---|
| Founded | N/A | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 924.5M |
| IPO Year | N/A | 2007 |
Fundamental Metrics
Financial Performance| Metric | NHP | SLS |
|---|---|---|
| Price | $15.15 | $12.54 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $10.00 |
| AVG Volume (30 Days) | 1.1M | ★ 10.9M |
| Earning Date | N/A | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 50.00 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $110.98 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $13.68 | $1.39 |
| 52 Week High | $15.63 | $15.88 |
Technical Indicators
Market Signals| Indicator | NHP | SLS |
|---|---|---|
| Relative Strength Index (RSI) | 60.08 | 57.58 |
| Support Level | $14.46 | $3.91 |
| Resistance Level | $15.51 | $15.88 |
| Average True Range (ATR) | 0.73 | 1.67 |
| MACD | 0.02 | -0.06 |
| Stochastic Oscillator | 63.66 | 54.47 |
Price Performance
Historical Comparison NHP
SLS
About SLS SELLAS Life Sciences Group Inc.
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.